Flow cytometric analysis of early and advanced gastric-cancer
1987-01-01 Leoncini, L.; Vindigni, C.; Minacci, C.; Nuti, S.; Lavarini, E.; Cintorino, M.; Pinto, E.; Destefano, A.; Tosi, P.
Ipilimumab in the common daily practice: Feasibility, safety, and efficacy in heavily pretreated metastatic melanoma patients
2009-01-01 Di Giacomo, A; Danielli, R; Calabrò, L; Guidoboni, M; Miracco, C; Biagioli, M; Mazzei, M; Altomonte, Maresa; Maio, M
Ipilmumab in pretreated metastatic uveal melanoma patiens; safety and clinical efficacy
2009-01-01 Danielli, R.; Queirolo, P.; Testori, A.; Plummer, R.; Razis, E.; Sileni Chiarion, V.; Calabrò, L.; Di Giacomo, A. M.; Ridolfi, R.; Maio, M.
Ipilmumab in the daily practice: feasibility, safety, efficacy and long term follow-up in heavily pretreated metastatic melanoma patients
2009-01-01 Di Giacomo, A. M.; Danielli, R.; Calabro, L.; Bertocci, E.; Nannicini, C.; Miracco, C.; Biagioli, M.; Mazzei, M. A.; Altomonte, M.; Maio, M.
The italian experience on the feasibility and safety of ipilmumab therapy in pretracted metastatic melanoma patients
2009-01-01 Altomonte, M.; Queirolo, P.; Testori, A.; Ascierto, P.; Danielli, R.; Di Giacomo, A. M.; Sileni Chiarion, V.; Del Vecchio, M.; Ridolfi, R.; Maio, M.
The Italian experience on the feasibility and safety of ipilimumab therapy in pretreated metastatic melanoma patients
2009-01-01 Altomonte, M; Queirolo, P; Testori, A; Ascierto, P; Danielli, R; DI GIACOMO, ANNA MARIA; Sileni Chiarion, V; Del Vecchio, M; Ridolfi, R; Maio, M
Bcg vs. Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio: Studio prospettico randomizzato
2008-01-01 Del Zingaro, M; Costantini, E; Lazzeri, M; Mearini, L; Mearini, E; Giannantoni, A; Zucchi, A; Joannidou, K; Bini, V; Porena, M
Desmopressin in the treatment of nocturia in patients affected by Parkinson's disease
2013-01-01 Giannantoni, A.; Proietti, S.; Gubbiotti, M.; Rossi De Vermandois, J. A.
Prognosis of adult acute myeloid leukemia in Southern Switzerland: A population-based analysis
2005-01-01 Lerch, E.; Espeli, V.; Zucca, E.; Ghielmini, M.; Leoncini, L.; Scali, G.; Mora, O.; Bordoni, A.; Cavalli, F.
Euro-FISH: A concerted action towards standardized translocation detection in pathology
2007-01-01 Van Rijk, A; Mason, D; Leoncini, L; Cabecadas, J; Hansmann, M; Bergman, Cc; Cigudosa, Jc; Anagnostou, Diamanto; Dutoit, Ss; Poulsen, Ts; Matthiesen, Sh; Van Krieken, H
Role of chromatin remodeling mediated by the HIV-1 Tat protein in the genesis of the HIV-1-associated malignancies
2008-01-01 De Falco, G; Cerino, G; Leucci, E; Nyagol, J; Cocco, M; Onnis, A; Tosi, P; Giordano, A; Leoncini, L
Phase II multicenter trial of ipilimumab combined with fotemustine in patients with metastatic melanoma: The Italian Network for Tumor Biotherapy (NIBIT)-M1 trial
2012-01-01 DI GIACOMO, ANNA MARIA; Ascierto, Pa; Pilla, L; Ridolfi, R; Santinami, M; Testori, A; Queirolo, P; Simeone, E; Guidoboni, M; Del Vecchio, M; Ferrucci, Pf; Marasco, A; Fonsatti, E; Annesi, D; Giannarelli, D; Parmiani, G; Maio, M
Safety and efficacy of ipilimumab 10 mg/kg among patients with advanced melanoma from Italy enrolled in a European compassionate use program (EAP)
2012-01-01 Maio, M; Queirolo, P; Testori, A; Altomonte, M; Maur, M; Bajetta, E; Ascierto, Pa; Chiarion Sileni, V; DI GIACOMO, ANNA MARIA; Ridolfi, R
Efficacy and safety of IPILIMUMAB in patients with pretreated, mucosal melanoma: experience from Italian clinics participating in the European expanded access program (EAP)
2012-01-01 Del Vecchio, M; Simeone, E; Chiarion Sileni, V; Nuzzo, C; Rinaldi, G; Testori, A; De Galitiis, F; Queirolo, P; Marconcini, R; Maio, M
Four-year survival update for metastatic melanoma patients treated with IPILIMUMAB plus plus DACARBAZINE on phase 3 study CA184-024
2012-01-01 Maio, M; Bondarenko, I; Robert, C; Thomas, L; Garbe, C; Testori, A; Francis, S; Chin, K; Wolchok, J
Five-Year survival Rates for patients (PTS) with metatastatic melanoma(MM) treated with ipilimumab (IPI) in phase II trials
2012-01-01 Lebbe, C; Weber, J; Maio, M; Neyns, B; Harmankaya, K; Chin, K; Mcdowell, D; Cykowski, L; Mchenry, B; Wolchok, J
Long term survival and immunological correlates in metastatic melanoma treated with IPILIMUMAB 10 mgs within an expanded access program
2012-01-01 DI GIACOMO, ANNA MARIA; Calabro, L; Danielli, R; Pesce, I; Fonsatti, E; Bertocci, E; Giannarelli, D; Biagioli, M; Altomonte, M; Maio, M
Updated overall survival (OS) results for BRIM-3, a phase III randomized, open-label, multicenter trial comparing BRAF inhibitor vemurafenib (vem) with dacarbazine (DTIC) in previously untreated patients with BRAF(V600E)-mutated melanoma
2012-01-01 Chapman, Pb; Hauschild, A; Robert, C; Larkin, Jmg; Haanen, Jbag; Ribas, A; Hogg, D; Hamid, O; Ascierto, Pa; Testori, A; Lorigan, P; Dummer, R; Sosman, Ja; Garbe, C; Maio, M; Nolop, Kb; Nelson, Bj; Joe, Ak; Flaherty, Kt; Mcarthur, Ga
Vigilance behaviour in roe deer: the role of group size, season and sex-age class
2018-01-01 Fattorini, N.; Lovari, S.; Ferretti, F.
Scale-dependent effectiveness of management in reducing deer impact on woodland
2018-01-01 Fattorini, N.; Watson, P.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Flow cytometric analysis of early and advanced gastric-cancer | 1-gen-1987 | Leoncini, L.; Vindigni, C.; Minacci, C.; Nuti, S.; Lavarini, E.; Cintorino, M.; Pinto, E.; Destefano, A.; Tosi, P. | - | |
| Ipilimumab in the common daily practice: Feasibility, safety, and efficacy in heavily pretreated metastatic melanoma patients | 1-gen-2009 | Di Giacomo, A; Danielli, R; Calabrò, L; Guidoboni, M; Miracco, C; Biagioli, M; Mazzei, M; Altomonte, Maresa; Maio, M | - | |
| Ipilmumab in pretreated metastatic uveal melanoma patiens; safety and clinical efficacy | 1-gen-2009 | Danielli, R.; Queirolo, P.; Testori, A.; Plummer, R.; Razis, E.; Sileni Chiarion, V.; Calabrò, L.; Di Giacomo, A. M.; Ridolfi, R.; Maio, M. | - | |
| Ipilmumab in the daily practice: feasibility, safety, efficacy and long term follow-up in heavily pretreated metastatic melanoma patients | 1-gen-2009 | Di Giacomo, A. M.; Danielli, R.; Calabro, L.; Bertocci, E.; Nannicini, C.; Miracco, C.; Biagioli, M.; Mazzei, M. A.; Altomonte, M.; Maio, M. | - | |
| The italian experience on the feasibility and safety of ipilmumab therapy in pretracted metastatic melanoma patients | 1-gen-2009 | Altomonte, M.; Queirolo, P.; Testori, A.; Ascierto, P.; Danielli, R.; Di Giacomo, A. M.; Sileni Chiarion, V.; Del Vecchio, M.; Ridolfi, R.; Maio, M. | - | |
| The Italian experience on the feasibility and safety of ipilimumab therapy in pretreated metastatic melanoma patients | 1-gen-2009 | Altomonte, M; Queirolo, P; Testori, A; Ascierto, P; Danielli, R; DI GIACOMO, ANNA MARIA; Sileni Chiarion, V; Del Vecchio, M; Ridolfi, R; Maio, M | - | |
| Bcg vs. Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio: Studio prospettico randomizzato | 1-gen-2008 | Del Zingaro, M; Costantini, E; Lazzeri, M; Mearini, L; Mearini, E; Giannantoni, A; Zucchi, A; Joannidou, K; Bini, V; Porena, M | - | |
| Desmopressin in the treatment of nocturia in patients affected by Parkinson's disease | 1-gen-2013 | Giannantoni, A.; Proietti, S.; Gubbiotti, M.; Rossi De Vermandois, J. A. | - | |
| Prognosis of adult acute myeloid leukemia in Southern Switzerland: A population-based analysis | 1-gen-2005 | Lerch, E.; Espeli, V.; Zucca, E.; Ghielmini, M.; Leoncini, L.; Scali, G.; Mora, O.; Bordoni, A.; Cavalli, F. | - | |
| Euro-FISH: A concerted action towards standardized translocation detection in pathology | 1-gen-2007 | Van Rijk, A; Mason, D; Leoncini, L; Cabecadas, J; Hansmann, M; Bergman, Cc; Cigudosa, Jc; Anagnostou, Diamanto; Dutoit, Ss; Poulsen, Ts; Matthiesen, Sh; Van Krieken, H | - | |
| Role of chromatin remodeling mediated by the HIV-1 Tat protein in the genesis of the HIV-1-associated malignancies | 1-gen-2008 | De Falco, G; Cerino, G; Leucci, E; Nyagol, J; Cocco, M; Onnis, A; Tosi, P; Giordano, A; Leoncini, L | - | |
| Phase II multicenter trial of ipilimumab combined with fotemustine in patients with metastatic melanoma: The Italian Network for Tumor Biotherapy (NIBIT)-M1 trial | 1-gen-2012 | DI GIACOMO, ANNA MARIA; Ascierto, Pa; Pilla, L; Ridolfi, R; Santinami, M; Testori, A; Queirolo, P; Simeone, E; Guidoboni, M; Del Vecchio, M; Ferrucci, Pf; Marasco, A; Fonsatti, E; Annesi, D; Giannarelli, D; Parmiani, G; Maio, M | - | |
| Safety and efficacy of ipilimumab 10 mg/kg among patients with advanced melanoma from Italy enrolled in a European compassionate use program (EAP) | 1-gen-2012 | Maio, M; Queirolo, P; Testori, A; Altomonte, M; Maur, M; Bajetta, E; Ascierto, Pa; Chiarion Sileni, V; DI GIACOMO, ANNA MARIA; Ridolfi, R | - | |
| Efficacy and safety of IPILIMUMAB in patients with pretreated, mucosal melanoma: experience from Italian clinics participating in the European expanded access program (EAP) | 1-gen-2012 | Del Vecchio, M; Simeone, E; Chiarion Sileni, V; Nuzzo, C; Rinaldi, G; Testori, A; De Galitiis, F; Queirolo, P; Marconcini, R; Maio, M | - | |
| Four-year survival update for metastatic melanoma patients treated with IPILIMUMAB plus plus DACARBAZINE on phase 3 study CA184-024 | 1-gen-2012 | Maio, M; Bondarenko, I; Robert, C; Thomas, L; Garbe, C; Testori, A; Francis, S; Chin, K; Wolchok, J | - | |
| Five-Year survival Rates for patients (PTS) with metatastatic melanoma(MM) treated with ipilimumab (IPI) in phase II trials | 1-gen-2012 | Lebbe, C; Weber, J; Maio, M; Neyns, B; Harmankaya, K; Chin, K; Mcdowell, D; Cykowski, L; Mchenry, B; Wolchok, J | - | |
| Long term survival and immunological correlates in metastatic melanoma treated with IPILIMUMAB 10 mgs within an expanded access program | 1-gen-2012 | DI GIACOMO, ANNA MARIA; Calabro, L; Danielli, R; Pesce, I; Fonsatti, E; Bertocci, E; Giannarelli, D; Biagioli, M; Altomonte, M; Maio, M | - | |
| Updated overall survival (OS) results for BRIM-3, a phase III randomized, open-label, multicenter trial comparing BRAF inhibitor vemurafenib (vem) with dacarbazine (DTIC) in previously untreated patients with BRAF(V600E)-mutated melanoma | 1-gen-2012 | Chapman, Pb; Hauschild, A; Robert, C; Larkin, Jmg; Haanen, Jbag; Ribas, A; Hogg, D; Hamid, O; Ascierto, Pa; Testori, A; Lorigan, P; Dummer, R; Sosman, Ja; Garbe, C; Maio, M; Nolop, Kb; Nelson, Bj; Joe, Ak; Flaherty, Kt; Mcarthur, Ga | - | |
| Vigilance behaviour in roe deer: the role of group size, season and sex-age class | 1-gen-2018 | Fattorini, N.; Lovari, S.; Ferretti, F. | - | |
| Scale-dependent effectiveness of management in reducing deer impact on woodland | 1-gen-2018 | Fattorini, N.; Watson, P. | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1865
Data di pubblicazione
- 2020 - 2025162
- 2010 - 2019719
- 2000 - 2009721
- 1990 - 1999226
- 1980 - 198934
- 1974 - 19793
Editore
- Elsevier1
- Eular Publishers:Missionsstrasse 36, CH-4012 Basel Switzerland:011 41 61 2646470, EMAIL: [email protected], Fax: 011 41 61 26464881
- F K Schattauer Verlagsgesellschaft mbH:Postfach 104545, D-70040 Stuttgart Germany:011 49 711 2298726, EMAIL: [email protected], INTERNET: http://www.schattauer.de, Fax: 011 49 711 22987501
- Firenze University Press1
- Fondaz Ferrata Storti:Strada Nuova 134, 27100 Pavia Italy:011 39 0382 531182, EMAIL: [email protected], Fax: 011 39 0382 277211
- JOHN WILEY & SONS LTD1
Rivista
- EUROPEAN JOURNAL OF PUBLIC HEALTH192
- MULTIPLE SCLEROSIS72
- URODINAMICA60
- EUROPEAN UROLOGY. SUPPLEMENTS39
- PEDIATRIC RESEARCH36
- ANNALS OF ONCOLOGY26
- THE JOURNAL OF UROLOGY26
- ACTA OPHTHALMOLOGICA24
- EUROPEAN RESPIRATORY JOURNAL23
- HELICOBACTER23
Keyword
- Hypoxia9
- Biomarkers8
- nonlinear analysis8
- Idiopathic pulmonary fibrosis7
- biomarkers6
- cirrhosis6
- thrombin6
- Caretta caretta5
- fractal analysis5
- botulinum a toxin4
Lingua
- eng1520
- ita130
- fre6
- und2
- ger1
- por1
- spa1
Accesso al fulltext
- no fulltext1291
- reserved464
- open93
- internalNetwork13
- partially open4
Appartenenza
- Dipartimento di Biotecnologie Mediche402
- Dipartimento di Biotecnologie, Chimica e Farmacia113
- Dipartimento di Filologia e Critica delle Letterature Antiche e Moderne5
- Dipartimento di Giurisprudenza2
- Dipartimento di Ingegneria dell'Informazione e Scienze Matematiche19
- Dipartimento di Medicina Molecolare e dello Sviluppo534
- Dipartimento di Scienze della Formazione, Scienze Umane e della Comunicazione Interculturale1
- Dipartimento di Scienze della Vita252
- Dipartimento di Scienze Fisiche, della Terra e dell'Ambiente103
- Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze879